The Left wails and snorts over the ban on Mifepristone.
That's because the Left doesn't give a rip about life--whether pre-born, or that of the mom.
...There is substantial evidence of the drug’s dangers. A groundbreaking study by the Ethics and Public Policy Center last year examined data from nearly 900,000 drug-induced abortions and concluded, “10.93 percent of women experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion.” Further, the EPPC researchers found that “the real-world rate of serious adverse effects following mifepristone abortions is at least 22 times as high as the summary figure of ‘less than 0.5 percent’ in clinical trials reported on the drug label.”...
Death and destruction, like lying, is a Biden thing.
2 comments:
No. It’s a freedom thing. When presented with those stats, many women STILL choose to take the drug.
Danco Laboratories is a pharmaceutical distributor located in midtown Manhattan which distributes the abortifacient drug Mifepristone under the brand name Mifeprex. Mifeprex is the only drug distributed by Danco, although the company plans to expand to other drugs in the future.
Danco is a private company that does not disclose the names of its investors, but stated that "[Investors] included wealthy individuals and foundations that supported abortion rights."
Outside the United States, mifepristone is distributed by the French pharmaceutical company Exelgyn, under the trade name Mifegyne.
April 14, 2026
Todd Blanche
United States Department of Justice
Acting United States Attorney General
950 Pennsylvania Avenue, N.W.
Washington, D.C. 20530
Dear Acting Attorney General Blanche:
I write to urge you to open an investigation into Danco Laboratories and its manufacture,
distribution, and marketing practices relating to mifepristone. Women are being harmed by this
chemical abortion drug at far higher rates than advertised on the drug label. As you may know,
this drug is now responsible for over 70 percent of abortions in the United States—a number which
has risen in just the last four years. Large, secretive pharmaceutical corporations like Danco must
be held accountable for these serious safety risks to women and the Department should take
immediate action.
Very little information is publicly available about Danco Laboratories. The company first
introduced mifepristone in the United States in 2000 and, in doing so, appears to have taken
unusual and extreme measures to protect itself from liability. It was incorporated in the Cayman
Islands. Its board of directors and investors remain secret. And its corporate structure remains
largely shielded from public view. Early backers appear to have included George Soros and other
far-left activists who favor population control.1 We do know, however, that chemical abortion is a
lucrative enterprise for Danco—so lucrative, in fact, that mifepristone is the only drug the company
makes, with investors’ returns reportedly topping 450%.
Yet Danco is profiting at the expense of women who have taken the drug and been seriously
harmed by it. The largest study of mifepristone ever conducted found that nearly 11% of women
who take the drug experience a “serious adverse health event,” such as sepsis or hemorrhaging.
That rate amounts to 22 times higher than what Danco admits to on its label. I recently hosted an
event which featured firsthand testimonies of women who were harmed by the drug. These women
deserve justice for what they suffered at the hands of this shady Big Pharma company.
You and the Department of Justice are tasked with upholding the rule of law and protecting every
American—including women that companies like Danco prey on and lie to. This mandate includes
ensuring Danco’s prompt, fulsome, and transparent compliance with all applicable laws,
regulations, and ongoing regulatory obligations. My Subcommittee has opened an investigation
into Danco and its business practices. I request that you also open an investigation into Danco,
including but not limited to its original FDA approval, ongoing regulatory compliance,
manufacture and distribution pipeline, potentially deceptive marketing practices, and disclosure of
safety risks pertaining to the drug.
The American public demands answers to the chemical abortion drug that is flooding into every
corner of the country—often contrary to state laws—and causing devastating harm to women and
babies, await your response confirming the initiation of your investigation.
Sincerely
Josh Hawley
United States Senator
Post a Comment